• Cell and Gene Therapy Access Challenges

  • Dec 4 2024
  • Duración: 53 m
  • Podcast

Cell and Gene Therapy Access Challenges

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In our second of three episodes in conjunction with members of ACCESS Forum, we engage with leading experts to uncover the multifaceted challenges of access and affordability in cell and gene therapies. Our conversation investigates how these treatments' innovative yet complex landscape leads to challenging regulatory pathways, pricing models, and reimbursement strategies.

    Alicia Silver, MPP, Head of Cell and Gene Therapy, ADVI Health
    Eric Faulkner, President, Passage Health Associates
    ADVI Health
    Alliance for Regenerative Medicine
    ARPA-H
    Bespoke Gene Therapy Consortium
    Blue Bird Bio
    Blue Cross Blue Shield
    Medicare DRG Rates
    NICE (National Institute for Health and Care Excellence)
    Novartis
    Passage Health Associates
    REMS Program
    Single Case Agreements
    Spark Therapeutics

    Medical terminology referenced in this episode:

    • Alzheimer's
    • Aspheresis
    • CAR T therapy
    • Hemophilia
    • Hepatitus C
    • Luxturna
    • Metachromatic leukodystrophy
    • Myeloablative Conditioning
    • Sickle Cell Disease
    • SMA treatment
    • Spinraza
    • Vaso Occlusive Crises
    • Zolgensma
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Cell and Gene Therapy Access Challenges

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles